We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Window-of-opportunity Study of Pelareorep in Early Breast Cancer (AWARE-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04102618
Recruitment Status : Terminated (Enrollment into AWARE cohorts1-4 have concluded and the primary objective and core goals for the study were met.)
First Posted : September 25, 2019
Last Update Posted : August 15, 2022
SOLTI Breast Cancer Research Group
Information provided by (Responsible Party):
Oncolytics Biotech

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : April 20, 2022
Actual Study Completion Date : April 20, 2022